Re: Thumbs up for Chris!
|
6
|
Resverlogix Corp.
|
Mar 29, 2022 05:39PM
|
Re: great,good,bad,ugly or so so??
|
6
|
Resverlogix Corp.
|
May 18, 2022 06:15PM
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
6
|
Zenith Epigenetics
|
Aug 16, 2017 03:33PM
|
Re: FA expectations
|
6
|
Resverlogix Corp.
|
Sep 20, 2017 10:13AM
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 24, 2021 06:43PM
|
Question re Hepa
|
6
|
Resverlogix Corp.
|
Oct 18, 2017 11:14AM
|
Re: https://themarkether...
|
6
|
Resverlogix Corp.
|
Feb 22, 2022 08:33PM
|
Re: Apropos AGM
|
6
|
Resverlogix Corp.
|
Jun 06, 2022 12:54PM
|
Re: Presentation is gone
|
6
|
Resverlogix Corp.
|
May 16, 2021 01:28PM
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
6
|
Zenith Epigenetics
|
Oct 05, 2020 07:08PM
|
AGM tomorrow
|
6
|
Resverlogix Corp.
|
Jul 30, 2024 08:54PM
|
Hump Day Fun
|
6
|
Resverlogix Corp.
|
Mar 29, 2023 11:22AM
|
Review of ZCC history
|
6
|
Zenith Epigenetics
|
Aug 27, 2023 12:06PM
|
Thoughts on Votes
|
7
|
Resverlogix Corp.
|
Jul 01, 2023 12:18PM
|
Covid still alive
|
7
|
Resverlogix Corp.
|
Mar 13, 2022 06:19PM
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
7
|
Resverlogix Corp.
|
Jun 14, 2020 11:56AM
|
Good news thoughts
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 10:53AM
|
Presentation
|
7
|
Resverlogix Corp.
|
Oct 04, 2021 05:03PM
|
Re: AGM attendance
|
7
|
Resverlogix Corp.
|
May 24, 2022 01:06PM
|
Re: Sep 30 AGM Notes - Detailed
|
7
|
Resverlogix Corp.
|
Oct 06, 2015 10:14AM
|